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I^ '^RODUCTION 
steroids, the derivatives of the perhydrocyclopentano-
phenanthrene nucleus, are widely distributed in nature and 
play an important role in the vital activities of living 
organisms. They have really, prodigious range of different 
biological and pnysiological activities which prompted the 
organic ch«nists to undertake the synthesis of heterosteroids 
of natural steroids in order to boost the all round activities. 
The physiological activities of steroidal hormones depend 
upon a number of factors including stereochemistry and over-
all shape of the molecule. 
The pharmacological testings, along with the 
synthesis of new steroidal analogues have now become a major 
pre-occupation with organic chemists and continue to fasci-
nate them the world over. 
In recent years, it has become evident that by 
modification or introducing the hetero-ring in the naturally 
occurring steroids, it is possible to increase or decrease 
certain physiological properties. These observations axe 
U 
stimujting the expansion of steroidal chemistry with unusual 
carbon frame work and uncommon substituents at different 
positions in steroid nucleus. 
: 2 : 
Our laboratory is mainly concerned with the synthesis 
of heterosteroids and their structure elucidation by chemical 
and spectral studies. An attempt has been made for the 
synthesis of halo derivative and its testing for the pharma-
cological activities along with the pharmacological testing 
of a steroidal thiazole. 
C H A P T E R - O N E 
T H E O R E T I C A L 
SYNTHESIS OF THIAZOLE : 
The five membered doubly unsaturated heterocyclic 
system containing one nitrogen and one sulfur atom is 
called thiazole but there are two possibilities for the 
arrangement of sulfur and nitrogen atoms in the ring : 
(I) Nitrogen and sulfur atoms are at l,2~positions with 
the three carbon atoms^ such an arrangement is known as 
isothiazole, (II) Nitrogen and sulfur atoms are arranged 
at l»3-positions and called as thiazole. 
S' 
(I) 
N o 
(II) 
The dihydrothiazoles (III) and (IV) are also called 
as thiazolines. Tetrahydrothiazole or thiazolidine (V) 
constitutes a well known and important class of compounds 
Many polycyclic and fused ring systems containing the 
thiazole nucleus are also known. 
N- H-M 
zy 
(III) 
^ s ^ 
(IV) 
H-N-
S 
(V) 
The history of true thiazole series began in 1879 
with the work of Hofmann, who prepared derivatives of 
benzothiazole, such as 2-chloroben2othiazole and 2-phenyl-
benzothiazole . Compounds containing the simple thiazole 
2 
nucleus were first reported by Hantzch and co-workers . 
After this work, knowledge of the thiazole system 
developed steading and many discoveries of commercial and 
biological interest gave impetus to the study. In 1888, 
Green described a yellow substance (Primuline base) and 
dihydrothio-p-toluidine that were obtained by fusion of 
p-toluidine with sulfur. These substances were immediately 
recognised as benzothiazole derivatives^. The investigations 
4 
by Bogert et al. , greatly extended this field and reported 
in a series of papers begining in 1922. In 1922 Mill^ 
recognised the value of cyanine dyes containing thiazole 
ring as photographic sensitizers. At about the same time 
2-fflercaptobenzothiazole was developed as rubber vulcaniza-
tion accelerator and many related compounds were investi-
A 7 
gated . Williams and et. al. demonstrated the existence of 
the simple thiazole ring in vitamin B (Thiamine), 
8—10 Miolati and Levi reported the preparation of 
4-methyl, 4-ethyl, 4-carbethoxy-^nethyl-, 4-phenyl-2-mercapto-
thiazoles (Vllla-d) by the condensation of the corresponding 
halomethyl ketones (Vla-d) with anuaonium dithiocaxbamate 
(VII). 
S 
R-C-CH2CI 
B (VII) 
(Via) CH3 
(VIb) C2H5 
(Vic) CH2-CCXDC2H5 
R-
V 
(Villa) 
(Vlllb) 
(VIIIc) 
(Vllld) 
XJLS. 
a 
CH3 
^2"5 
CH^C00C2Hg 
Ph (VId) Ph 
2-MethyIthio-4-methylthiazole (DC) was prepared by 
•J 1 1 0 
the reaction of chloroacetone (Via) with dithiocarbamate ' . 
N-
CH3 
CH3-i 
(IX) 
13 Singh et al. reported that reaction of u-(6-methyl-
4-pyriinidinylthio)acetophenone (X) and 2-(6-methyl-4-
pyrimidinylthio)cyclohexanone (XI) with aq. HCl/HClO^ or 
POCI3 followed by hydrolysis provided l-(4-aryl-2-thiazolyl) 
-2-propanone (XII) and 4,5,6,7-tetrahydro-2-acetonyl benzo-
thiazole (XIII), respectively. 
>—CHO-C-CAH, 2^'~^6"5 
(X) 
^ 6 » 5 
(XI) ..3 
(XIII) 
14 Meakins et al. reported that the reaction between 
N-benzoyl-N*-iBethyl-N«-phenylthiourea (XIV) and chloro-
acetone (Via) gave 5-benzoyI-4-methyl-2-(N-inethyl-N-phenyl 
amino)thiazole (XV). 
0 
Ph-d-NH ,Ph 
0 CH, 
C6H5 
CH. 
/H3 
( I 
6"5 
(XIV) (XV) 
The reactions of dithlocyanates (XVI-XVIII) with 
p-methoxyaniline (XIV) in hot benzene afforded the dihydro-
thiazoles (XX-XXIl)"^^. 
• 7 • » I » 
NCS 
SCN 
(XVI) 
(XVII) 
(xvm) 
H 
R 
H 
CH3 H 
CH3 CH3 
2 cH^o-\0\-^m^ 
(XIX) (XX) 
(XXI) 
(XXII) 
CH3 H 
CH3 CH3 
Condensation of 2-chlorocyclohexanone (XXIII) with 
substituted thioamide (XXIV-XXX) in hot ethanol gave 
2-substituted 4,5,6,7-tetrahydroben2othiazole derivatives 
(XXXI-XXXVII)^^. 
(XXIII) (XXIV) 
(XXXI) 
8 
H2-NH-C-NH2 
O 
(XXV) 
NH-6-NH2 
(XXVI) 
CI 1 S 
(XXVII) 
(XXVIII) 
NH 
CH. 
(XXXIII) 
(XXXIV) 
H3C 
(XXXV) 
s 
NH-C-NH. 
CX:H. 
(XXX) 
(XXXVI) 
OCH, 
(XXXVII) 
The condensation of a-bromoketone (XXXVIII) with 
N-methyl thiourea (XXXIX) in neutral solvent afforded 
exclusively 2-NHattethylamino-(4-^substituted)thiazoles 
(XL)^"^. 
CH3 
^Br 
(XXXVII) 
HgC^  
CH3NH-C-NH2 
(XXXIX) (XL) 
-NH-CH-
10 
The reaction of 2-an!ino-4-chlorothlophenol with 
various aldehydes and ketones have been studied extensi-
During the last few years, a large number of steroidal 
thlazoles have been synthesised by different routes. When a 
mixture of 0-toluldlne-hydrochlorlde and 2a-thlocyanato-17a-
methyl-androstan-3-en~17p-ol (XLIJ in ethanol was refluxed 
with ethyl acetate provided 17a-methyl-17p-hydroxyandrostano 
[3,2-dJ-2*,3*-dlsubstltuted thlazollnes (XLII-XLIV)^^. 
NCa, 
(XLII) 
(XLIII) (XLIV) 
11 
When 3p-acetoxy-5a-androstan-(6a-broino-17-one) (XLV) 
was treated with thiourea provided 3p-acetoxy-5a-androstano 
[l7,16-dJ-2«-aminothiazole (XLVI)^ -'-. 
AcO ^ 
(XLV; (XLVI) 
Similar treatment of 17p-acetoxy-2a-bromo-5a-andro-
stan-3-one (XLVII) and 2a-bromo-5a-cholestan-3-one (XLVIII) 
with thiourea in isopropyl alcohol prpvided 17p-acetoxyl-
5a-androstano[3,2-d]-2*-aminothiazole (XLIX) and 
5a-cholestano[3,2-dj2*-aminothiazole (L)^^. 
PAc OAc 
12 
CQHI-J CQH^7 
The Pharmacological Studies of Steroidal Thiazole : 
The substituted thiazoles have been reported to 
possess many important pharmacological actions which prompted 
22 
us for the studies. Irismetov et* al. have reported 
certain thiazolosolasodanes possessing antimicrobial 
activity. Some guanidinothiazoles synthesised, in the 
23 Imperical Chemical Industries Ltd. , possess antihistamlnic 
24 
actions. Tartler and Weuffen reported fungistic proper-
ties of some thiazole and thiazole derivatives, 
25 Joshi et. al. synthesised some fluorine containing 
2-(N-aryl amino/or -methyl-4-aryl)thiazoles showing the 
Oft 
antibacterial activity. Sawney and Arora have studied 
the antiinflaraipatory activity of some 2*~Alkyl/Aryl-2-
aryl-4-fljethyl--4*,5'-bithiazolyls and 2*-amino substituted 
amino-2-aryl-4-methyl-4*,5-bithiazolyls by carrageenin 
oedema test in rats. 
13 
-<oH. 
9^3 
N r 
(I) R = H, (LII) R = CI CLIIi; R = 0-CH3 
[LI, LII and LIII - Bithiazolyls] 
They found the compound to inhibit the oedema by 16 
to Al% at the dose of 100 mg/kg. The highest activity was 
found in the compounds possessing anisyl groupings with 
thiazole moieties. The L D ^ for the compound was 800 mg/kg 
or more. The compounds were also treated in vitro for anti-
tubercular activity against \h* tuberculosis but were found 
to be inactive, 
27 Sawney et« al. synthesized as well as tested for 
antiinflammatory activity of some 2-(2-amino-4-thiazolyl)-
benzothiazoles also. The activity was measured in rat by 
'Carrageenin in foot oedema testt Groups of 5 adult rats 
were used for each dose of 100 mg/kg of the test compounds 
which were administered interaperitoneally 1 hour before 
injecting Carrageenin and the volume of the foot was measured 
14 
3 hours after injection. The results were given in term 
of percentage {%) with respect to the controlled. The 
percentage inhibition for the different drugs is as ; 
(iv) 609S, (v) b6%t (vi) 41%, (vii) 61%, (viii) b8%. 
NHR< 
(LIV) R=H, R*=H (LV) R=H, R*=Ph (LVI) R=H, R'=p-C1C^H^ 
(LVII) R=H, R'sO-CHgC^H^ (LVIII) R=H, R«=p-CH3-0-C^H^ 
steroidal Thiazole and its Biological Activities s 
The non-steroidal substituted thiazoles have been 
22—27 
reported to possess biological activities . These 
reported observations prompted to synthesise the steroidal 
thiazole (LX) from easily accessible steroidal a-brcwjo-
ketone (LIX) with the reaction of thiourea. 
CQHU 
(LIX) (LX) 
Reaction of 3B-acetoxv-7a-bromQ-5tt-cholest-6-one with 
thiourea : 
3p-Acetoxy-7a-bromo-5a-cholest-6-one (LIX) was 
refluxed in ethanol with thiourea for a period of 8 hours. 
The mixture was diluted with water and extracted with ether. 
The ethereal layer was washed with water and dried over 
anhydrous sodium sulfate and crystallised which provided a 
compound having m.p. 202 C. 
16 
Characterisation of the compounci. m.p. 202^C as 36~acetoxv-
2*-amino-5a-cholest-6"anof6.7-d1thiazole (LX) ; 
The compound (DC) was analysed correctly for 
^30^48'^2^2^* ^^^ ^^ spectrum of the compound showed weak 
absorption bands at 3450, 3300, 3150 cm" and strong absorp-
tion bands at 1730, 1265 cm" which are due to presence of 
NH2 and acetate groups. Other bands were observed at 1630 
(C=C), 1525 (C=N), 1460, 1375 (C-N) and 665 (C-S). These 
28 
values indicate the presence of thiazolyl moiety in the 
steroid nucleus. The H-NMR spectrum of the compound dis-
played a broad singlet at d 5.3 integrating for two protons 
assigned to -^^2 (exchangeable with deuterium) and other 
broad multiplet centred at d 4.71 for C3a-H (Wl/2 « 18Hz)^^, 
The signal at d 2.05 integrating for three protons was due 
to acetyl methyl. Angular and side chain methyl protons 
were observed at d 1.2 (C^Q-CH^), 0.78 (CJL3-CH2) and 0.91, 
0.81. On the basis of these analytical and spectral data, 
the compound, m.p. 202°C was characterized as 3p-acetoxy-
2*-amino-5a-cholest-6-ano[6,7-d]thiazole (LX) . 
A new thiazole, 3^-acetoxy-2*-amino-5a-cholest-6-
ano[6,7-dJthiazole was subjected to the brief preliminary 
screening at the various doses for the biological activity. 
17 
The substituted thiazoles have not yet been reported to 
possess central actions even though the compound was tested 
for neuropharmacological actions, as it is usual to begin 
with 'Blind Screening in this manner*. As the other thia-
24—27 
zoles have been shown to possess antiinflammatory 
action, therefore, the test compound was studied for that 
action also. 
The observation that the test compound reduced the 
frequency, co-ordination of movements and palpebral 
aperture indicates that it possessed central depressant 
action. The depression of the rate of the respiration and 
decrease in the body temperature would be due to specific 
central actions or be a part of generalised central depre-
ssion. The reduction in the tone of the limbs and abdomen 
could be due to effect on motor centres and tracts or due 
to generalised central depression. The increase in reaction 
time to thermal pain producing stimulus indicates the 
presence of analgesic action probably of the opioid type. 
The observation of Straub*s response in the animals treated 
with the highest dose supports this inference. The pro-
longation of the reaction time to mechanical nociceptive 
stimulus by the highest dose indicates anticonvulsant 
action . The absence of touch response in the animals 
treated by highest dose could be due to interference in the 
18 
sensory path way but it is more likely that reflects a 
greater central depression. The near absence of spontaneous 
locomotion as well as almost instaneous effect observed with 
the highest dose indicates that it produces more intense 
central depression and supression of pain produced mecha-
nical stimules indicates that it also has some additional 
central action as compared to the lower doses. However, the 
20% mortality produced by the dose reflects its toxicity. 
The absence of any effect on the pinna and corneal reflux 
shows that the test compound does not block the reflex path 
way. The fact that the test compound did not produce exo-
phthalmo usand did not increase laerimation, salivation and 
urination indicates that it lacks effect on Autonomics 
Nervous System. The thiazole produced highly significant 
inhibition of carrageenin induced oedema, thus it is seen 
to possess antiinflammatory activity. 
The present study therefore reveals that the test 
compound i.e. 3p-acetoxy-2*-amino-5a-cholest-6-ano(6,7-d) 
thiazole possesses central depressant action and analgesic 
action at the dose of 5 mg/kg body weight. It may also 
possess central muscle relaxant action and specific respi-
ratory depressant and hyperthermic action. The analgesia 
could probably be of the opioid type. The highest dose i.e. 
19 
30 mg/kg possesses more Intense central actions and 
probably additional central action such as anticonvulsant 
action. The study also demonstrates that the compound 
possesses highly significant antiinflammatory activity. 
The later effect has been seen in other thiazoles but the 
nu«nerous neuopharmacological actions have been shown for 
the first time in this compound. 
'The neuropharmacological and antiinflammatory action 
of a new thiazole compound*. 
K.M. Yusuf Amin, Shafiullah, Ishrat H. Siddiqi and 
Hao Uwais Ahmad Khan. 
* 
Pharmacology Section, Department of Ilmul Advia, 
A.K. Tibbiya College, A.M.U. and 
Steroidal Research Laboratory, Department of Chemistry, 
Aligarh Muslim University, Aligarh-202 002. 
29th Annual Convention of Chemists, MED-22, H-10 (1992). 
E X P E R I M E N T A L 
EXEPRIMENTAL : 
All melting points were observed on a Kofler hot 
block apparatus and are uncorrected. IR spectra were 
obtained in Nujol with a Pye-Unicam SP3-1CX) Spectrophoto-
meter. IR values are given in cm" . H-NMR spectra were 
run in CDCl^ on a varian A-60D instrument with Me.Si as 
internal standard. Values are given in ppm (d). T.L.C. 
plates were coated with silica gel and sprayed with 209i 
aqueous solution of perchloric acid. 
36~Acetoxvcholest-5~ene (LXI) : 
A mixture of cholesterol (50 g), pyridine (75 ml, 
freshly distilled over KOH) and acetic anhydride (50 ml) 
was heated on a water bath for 2 hours. The resulting 
brown solution was poured on to crushed ice-water mixture 
with stirring. A white solid thus obtained was filtered 
under suction and washed with water so as to remove pyridine 
and air dried. The crude product on recrystallisation from 
acetone gave pure 3p-acetoxy tholest-5-ene (47.0 g), 
m.p. 115°C (reported'^ ,^ m.p, 116°C). 
21 
3B-Acetoxv-6-nitrocholest~5~ene (LXII) ; 
3p-Acetoxycholest-5-ene (10 g) was covered with nitric 
acid (250 ml; d 1.52) and sodium nitrite (lO g) was gradually 
added over a period of 1 hour with continuous stirring. 
Slight cooling was also maintained during the course of 
reaction. Stirring was continued for 2 hours more. When 
the yellow spongy mass was separated on the surface of the 
mixture, it was diluted with cold water. The whole mass was 
extracted with ether and washed with water and sodium bi-
carbonate ^5^) and water. The ethereal layer was then 
dried over anhydrous sodium sulfate. Removal of the solvent 
provided oil which was crystallised from methanol to yield 
(LXII) (6.8 g), m.p. 103° (reported^^, m.p. 102-104^0. 
36-Acetoxv-5a~cholestan-6-'one (DCIII) : 
3p-Acetoxy-6-nitrocholest-5-ene (6.0 g) was dissolved 
in acetic acid (250 ml) and zinc dust (12 g) was added in 
small portions with shaking. The suspension was heated 
under reflux for 4 hours, water (12 ml) was added during the 
reaction. The hot solution was filtered, cooled to room 
temperature and diluted with water. The precipitate obtained 
was taken in ether and ethereal layer was washed with water, 
sodium bicarbonate solution {5%) and water and dried over 
22 
anhydrous sodium sulfate. Removal of the solvent gave an 
oil which was crystallised from methanol to give the ketone 
(DCIII) (3.9 g), m.p. 128° (reported^ **, m.p. 127-128°C). 
g-Bromination of 33-acetoxv-5a-cholestan-6-one (LXIII) i 
3B-Acetoxv-7a-bromO"5a-cholest-6-one (LIX) : 
A solution of bromine (2.12 g Br2 in 25 ml acetic acid) 
was added dropwise to a solution of 3p-acetoxy-5a-cholestan-
6-one (LXIII) (6.0 g, in 75 ml ether and 15 ml acetic acid) 
and was refluxed for 22 hours. After usual work up and 
evaporation of the ether gave an oil which on crystallisa-
tion from methanol provided bromoketone (LIX) (5.2 g), 
m.p. 146° (reported , m.p. 145°C). 
Reaction of 3B-acetoxv~7a-bromo-5tt-cholestan-6-one (LIX) 
with thiourea : 3g"Acetoxv-'2*'-amino-'5a~cholest-6~ano 
f6.7^1thiaZQle (LX) : 
3^-Acetoxy-7a-bromo-5a-cholestan-6-one (LDC) (1.25 g) 
in ethanol (25 ml) was refluxed with thiourea (0.181 g) for 
8 hours. The reaction mixture was diluted with water and 
extracted with ether. The ethereal layer was washed with 
water and dried over anhydrous sodium sulfate. Evaporation 
23 
of the solvent gave an oil which was crystallised from 
petroleum benzene to provide the thiazole (LX), 0,875 g, 
m.p. 201°C (reported^^, m.p. 202*^C). 
Analysis found : C, 71.8; H, 9.5; N, 5.6 
Required : C, 72.0; H, 9.6; N, 5.6^ 
I«R« s V « . 3450, 3300, 3150 (NH^), 1730, 1265 (CHoCOO-) 
and 1630 (C=C), 1525 (C=N), 1460, 1375 (C-N) and 
665 cm"-"- (C-S). 
H-NMR : d 5.3 (brs, I^, exchangeable with deuterium), 
4.71 ihrm, Wl/2 = 18Hz; CSa-H), 2.05 (s, CiigCOO-), 
1.20 (0^0-013), 0.78 (Cj^3-CM3), 0.91 and 0.81 
(other methyl protons). 
PHARMACOLOGICAL TESTING : 
Gross behaviour test of 36<-acetoxv-2*-amino-5a-'Cholest-
6-anof 6.7-d1thiazole : 
It was carried out in mice by the method of Smith 
37 
modified by us in the light of Irwin's method . This 
is a simple and conq^rehensive test detecting a large number 
of neuropharmacological actions. As the test compound lacks 
pharmacological history, therefore, the first dose used was 
30 mg/kg body weight of animals. However, lower doses were 
24 
used subsequently as the above dose produced some mortality. 
The compound was dissolved in propylene glycol and adminis-
tered intraperitoneally. The effect of the steroidal thia-
zole was studied at the dose of 5 mg/kg, 10 mg/kg, 20 mg/kg, 
25 mg/kg and 30 mg/kg. Each dose was tested in 6 mice of 
either sex weighing 20-25 gms. The animals were observed 
for various parameters listed in Table-I. The mechanical 
and thermal nociceptive stimulus was given by applying a 
sheathed bull dog clamp at the tail and by placing the 
animal on Eddy's Hot Plate at 55.5°C respectively. A group 
of 6-untreated mice was used for 6 hours and then at 24 
hours. They were observed subsequently for mortality at 
24 hours for 6 days. 
In the gross behaviour test, it was observed that all 
the doses of the test compound reduced the spontaneous 
locomotion and made the movements uncoordinated. The pal-
pebral aperture was reduced. The rate of respiration was 
decreased and the depth increased. The body temperature, 
was observed by palpation, was reduced and piloerection was 
produced. The limb and abdominal tone was reduced but 
pinna reflex and corneal reflex were uneffected. Lacrima-
tion, Salivation and excessive urination were not observed. 
The defecation was normal. The reaction time to the 
thermal and mechanical pain producing stimulii was increased. 
25 
Straub's response was observed in half of the animals 
administered with the highest dose. One of the animal 
was found to be dead on the 3rd day. The effect of highest 
dose developed instaneously, while the rest of the doses 
produced the effect 15 minutes after drug administration. 
The finding are presented in Table-I. 
TABLE-I Effect of various doses of steroidal thiazole (LX) 
s. 
No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
on behaviour of mJLce 
Parameters 
Time of first 
unusual S/S 
Movements 
Coordination 
Pailpebral-
aperture 
Alertness 
Grooming 
Restlessness 
Stereotypy 
Tremor 
Convulsions 
Rate of 
respiration 
Depth of 
respiration 
3p-Acetoxy-2*-. 
thiazole 
5 mg/ 
kg 
15 
mints 
^ 
i 
N 
A 
A 
A 
A 
1 
t 
10 mg/ 
kg 
15 
mints 
I 
i 
4 
N 
A 
A 
A 
A 
i 
f 
amino-
20 m 
kg 
15 
mints 
^^  
^^  
N 
A 
A 
A 
A 
i 
t 
5a-
ig/ 
•cholest-^  
25 mg/ 
kg 
15 
mints 
4 
si^ 
^ 
N 
A 
A 
A 
A 
v^  
t 
)-anoL6,7-d 
30 mg/kg 
0 
mints 
si/ 
^ 
N 
A 
A 
A 
A 
^ 
t 
26 
TABLE-I Contd.... 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
Body 
temperature 
Piloerection 
Limbtone 
Abdominal tone 
Pinna reflex 
Corneal reflex 
Laerimation 
Salivation 
Urination 
Excessive 
defecation 
Startle 
response 
Touch response 
Straub*s response 
Mortality 
i 
4-Ve 
1 
^ 
N 
N 
A 
A 
N 
No 
+ve 
+ve 
-ve 
Nil 
I 
+V& 
^ 
^ 
N 
N 
A 
A 
N 
No 
+ve 
+ve 
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N = Normal, A = Absent, +ve = Positive, -ve = Negative 
Carraaeenin Induced Oedema Test of 3B-acetoxv-2*-amino-5tt-
cholest-6-anor6.7-dlthiazole (LX) : 
It was carried out in albino rats of either sex weighing 
150-200 gms by the method of Winter et. al.^® Twelve rats 
were devided into 2 groups of 6 animals each. The animals in 
27 
the test group were administered with 17«5 mg/kg of the 
test compound dissolved in propylene glycol (injected intra-
peritoneally))while the control animals were administered 
with equal volume of propylene glycol in the same manner. 
One hour later 0.05 ml of 1^ solution of carrageenin in 
normal saline was injected subcutaneously under the plantar 
aponeurosis of the right paw of all the animals. The thick-
ness of the paw was measured by an electronic micrometer 
before the injection of the carrageenin and 3 hours after 
it. The mean increase in thickness of the control and 
test groups was compared by student's 't* test and the 
percentage inhibition of the thickness in the animals was 
also calculated. 
In the carrageenin induced oedema test, it was found 
that the mean increase in thickness of the right hind paw 
was 2.34 +. 0.54 mm in the control animals while in the test 
animals it was found to be 0.86 + 0.09 mm. Thus increase 
in the hind paw thickness was greatly reduced in the test 
animals (p < 0.01). The percentage inhibition of thickness 
in the test animals was to be 66.65!i. The results are 
summarised in Table-II. 
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C H A P T E R - T W O 
T H E O R E T I C A L 
SYNTHESIS OF STEROIDAL KETONES AhP THEIR BROMINATION 
The development of new reaction pathways in the 
synthetic organic chemistry by oxidation methods have been 
very much useful for the organic chemists. Succeptibility 
of alkenes and hydroxy group to the electrophilic attack 
and their capability to reduce most of the oxidants moti-
vated the chemists to study the oxidising effects of 
transition metal ions and oxides on alkenes and hydroxy 
group. The importance of metal ion as oxidants is due to 
their low cost, stability and considerably selectivity with 
respect to functional groups by virtue of their action. 
The most commonly used inorganic oxidants are 
Potassium permanganate. Osmium tetraoxide, Ruthenium 
tetraoxide, Palladium chloride. Potassium peroxydisulphate 
and certain chromium and mercury salts. Besides these, 
some organic complexes of these metals are also used for 
example Pyridinium dichromate, Butyl chrornate etc. 
The oxidation of alcohols mainly give carbonyl 
compounds. The primary alcohols give rise to the aldehydes 
and secondary alcohols yield ketones. While alkenes 
undergo either exhaustive oxidation or allylic oxidation 
depending upon the reaction conditions, reagents used and 
35 
also upon the nature of oxidants. In some cases» the 
reactions take place at room temperature but in most of the 
casest the reactions are carried out at elevated tempera-
tures and in some of the cases the reactions even take place 
at low temperatures to avoid the extensive oxidation. The 
products of these oxidations from olefins are ketones, 
a-ketols and other degraded products. 
2 
Windus and Naggatz reported the oxidation of choles-
teryl acetate (I) with chromic acid in acetic acid which 
yielded cholesta-3,5-dien-7-one (II}. 
CQHJ_7 
(I) (II) 
3 4 
Fieser et. al. * identified the oxidation product 
of Windus and Naggatz obtained by chromic acid oxidation 
from epicholesteryl acetate (III) as 5-acetoxy~5a-
cholestan-3,7-dione (IV) and suggested the intramolecular 
C^-Cg acyl migration. 
36 
CQH^J 
AcO-
(III) 
The formation of a,p-unsaturated ketones has also been 
reported from the oxidation of steroidal alkenes with chromic 
acid. Marshall et. al. reported the introduction of ketone 
(VI) at C-7 of pregnelone acetate (V) using sodium chromate 
in acetic acid - acetic anhydride solution. I 
cholesteryl acetate iVII) with chromium trioxide and acetic 
acid yielded five products^ (VIII-XII). Cholesteryl acetate 
{D with chromic acid gave 5,6-seco product (XIIl). 
(V) (VI) 
37 • ^ T * 
CQH^J CQH.^7 
(VII) (VI I I ) 
AcO 
CgHjy ^8^17 
(X) 
AcO 
(XI) 
CgH^y 
( I ) 
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o 
Corey and Suggs have studied the use of Pyridinium 
chlorochromate as oxidant. They reported the advantage of 
this reagent over others and showed that it can be prepared 
easily, safely and also possesses high capability to 
convert primary alcohols into aldehydes in better yield. 
Cr03 + HCl — ± HCrOgCl ^ > [CrO^Cl]' 
R - CH - R* + \C)\ [CrOXl]" > R - - R* 
William and co-workers reported the oxidation of 
olefins (I, XIV-XXVI) with chromium trioxide-pyridine 
coi^lex at room temperature and obtained the following 
products (XXVII-XLV) in good to moderate yield. 
Olefin 
Okc 
Ketone 
Acer ^ ^ AcO-'^X^'-'^^^^^O 
(XIV) (XXVII) 
( I ) (XXVIII) 
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CgHj_7 
(XV) 
(XVI) (XXX) 
(XVII) (XXXI) 
40 
(XVIII) 
Y^""^ """ 
(XXXII) 
(XIX) (XXXIII) (XXXIV) 
(XX) (XXXV) (XXXVI) 
(XXI) (XXXV I D 
0 
(XXII) (XXXVIII) (XXXIX) 
41 i t X • 
C6H5 C6H5 H5C, C^H^ 
(XXIII) (XL) (XLI) 
^6"5 
(XXIV) (XLII) 
F 
(XXV) 
(XXVI) (XLIV) (XLV) 
42 
Wender et. al. reported the oxidation of 1,4-diene 
(XLVI) by Pyridinium chlorochromate and obtained dienones 
(XLVII) and (XLVIII). Marshall and Wuts^^ reported on ana-
logous behaviour of 1,4-diene (XLIX) with Pyridinium 
chlorochromate which yielded two products (L and Ll). 
(XLVI) (XLVII) (XLVIII) 
COOR COOR 
(L) 
COOR 
(LI) 
12 Djerassi and Lenk reported the use of N-iodosuccini-
mide for the synthesis of iodoketones. They treated 
steroidal enol acetate (LII) with N-iodosuccinimide and 
obtained 21-iodopregnenolone acetate (LIII). Muller and 
13 Jones prepared, a-iodoketone (LV) from the enol acetate 
(LV). 
43 
•-OAc 
(LID (LIII) 
OAc 
(LIV) (LV) 
14 Siemann et. al. reported the preparation of 
3p-substituted (20S)-20-[benzenesulphonyl)methyl]pregn-5-
en-7-one (LVII) from respective 3p-substituted (20S}-20-
[(ben2enesulphonyl)methyl]pregen-5-ene (LVI), 
(LVI) (LVII) 
44 
Cholesterol (LVIII) ubiquitously present in mainmalian 
tissues is subjected to autoxidation by air» peroxidation 
in vivo and raetabolisra. These intriguing events and biologi-
cally active oxysterols (LIX - LXXIV) thus produced, were 
reviewed in detail 15-17 
Qs^l7 
OOH OK 
(DC) 
OOH 
(LXI) (LXII) (LXIII) 
^8^17 
(DC IV) (D(V) (DCVI) 
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?8"l7 
(LXVII) (LXVIII) 
(DCX) 
o^^^yJ 
OH 
(LXXI) 
OH 
(LXXII) (LXXIII) (LXXIV) 
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BRQMINATION 
The ketones are brominated ordinarily in the presence 
of added or generated hydrogen bromide resulting, thereby, 
the formation of thermodynamically more stable product. In 
case of kinetically controlled bromination, the reaction may 
be effected by carrying out in the presence of an agent 
capable of removing hydrogen bromide as it is formed e.g. 
sodium acetate or by brominating the corresponding enol 
acetate in the presence of pyridine, sodium acetate or epi-
18 
chlorohydrin. The kinetic product may be the same as the 
19-21 thermodynamic one or different from it depending on 
steric factors. 
a-Bromination of methylene and methyl ketones in the 
presence of base can not be stopped at the monobromoketone 
stage. The polybromoketones, thus, formed are cleaved under 
the basic conditions to form halof.orm and carboxylic acid. 
The study of a-bromocyclanones is advantageous for two 
causes, first these compounds contain two strong dipoles, in 
close proximity, which are mutually repulsive to the 
greatest extent when steric strains are at a minimum and 
second, the approximate relative orientations of the two 
dipoles can be determined with the help of infrared spectro-
22 
scopy. It was Corey *• who advanced the theoretical arguments 
47 
led to the conclusion that a-bromocyclohexanone should 
exist almost completely at room temperature occupied axial 
position. 
It was obsei-vedy with the help of infrared spectro-
22 
scopy , that in methylated-2-broroocyclohexanones, the 
orientation of bJtomine in the stable conformation is some-
times axial and Sometimes equatorial. Hence, in case of 
2-bromo-3,3-dimethylcyclohexanone the more stable conforma-
tion is (DOCV-a, axial) and in the 4,4-dimethyl isomer, it 
is (DCXVI-e, equeitorial^ In (LXXV-e} the electric repulsion 
between C=0 and C-Br dipoles destabilizes it to the extent of 
CH3 (UCXV.es) 
(UXVI-e) 
L. 
H 
v 
(Lxxv-a) 
(LXXVI-a) 
Br 
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some 2.7 K. cal/mole, while steric interactions between 
1:3 H:Br in (LXXV-a) is found to destablise it by only about 
0.4 K. cal/mole. So (LXXV-a) predominates over (DOCV-e). 
In case of the 2-bromo-4,4-dimethylcyclohexanone, however, 
steric repulsion between axial bromine and axial methyl in 
(LXXVI-a) out weighs the electrical effect in (IXXVI-e) and 
Br-equatorial is more stable. In case of steroidal bromo-
ketones, these have achieved the conformation of maximum 
stability and the ring can not flip from one chair from to 
other. Although, a few bromoketones are known both in liable 
and stable forms, usually recognisable from the observation 
that under catalysed by HBr, the former can be isomerised to 
the later and the equilibrium is achieved by the enol forms. 
23 Corey characterised the bromination of steroidal 
ketones via the corresponding enols in several cases, and 
perhaps, generally by an effect which directs the incoming 
bromine substituent to the axial rather than the equatorial 
position. This is an indication that the axial epimer is 
formed faster rather than the equatorial one, opposing this 
effect is the classical steric effect which directs a large 
substituent such as (Br) to the less crowded equatorial 
orientation. The net result of these two effects which 
influence the relative rates of formation of the epimers with 
axial and equatorial bromine is clear in those cases where 
the bromoketone which is isolated as the unstable epimer. 
49 
formed for kinetic rather than for steady state reasons. 
In such instances the importance of the non-steric effect is 
apparent since the major product has invariably been found 
to be the epimer with axial bromine. 
22 Corey has also developed a rule for predicting the 
orientation of bromine in all a-broraoketosteroids with 
ketones function in ring A, B or C and A/B cis or trans. One 
method applies to the stereochemistry of thermodynamically 
controlled bromination products and the other method applies 
to a-bromoketosteroids whose stereochemistry is kinetically 
controlled. In every case there is agreement between predic-
ted and determined configuration at C (Br). In a number of 
cases it has been reported that the redetermination has been 
led by the prediction (and eventually reassignment of 
configuration). It has been shown, with exception, that the 
bromination of ba,6p-dibromocholestan-3-one produced the 
4a-derivative faster than the 4p-derivative although the 
latter is more stable. Similarly, the bromination of 3a-
acetoxy-5a-cholestan-6-one afforded, as predicted, the 
5a-bromo derivative which is isomerised to the 7a-bromo 
derivative by hydrogen bromide. 
23 
Corey generalised the prediction for the stereo-
chemistry to the kinetically controlled brominated products 
and the prediction is as *the epimer which is formed faster 
50 
in the bromination of ketosteroids is that in which bromine 
is axial*. 
24 Sigg et al. carried out the bromination of 5a-choles-
tan-1-one (LXXVIl) with bromine in acetic acid in the 
presence of HBr (as catalyst) at room temperature and 
obtained three compounds, 2p-bromo (LXXIX), 2a,2^-<libromo 
(LXXVIII) and 2a-bromo ketones (LXXX). 
98^17 
0 
Br-
(LXXVIl) (LXXVIII) 
H 
(LXXIX) 
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3a-Bromo-5a-cholestan~2.-one (LXXXII) was obtained 
from 5a-cholestan-2-one (LXXXI) by the treatment of bromine 
in acetic acid containing a trace of HBr. 
QQH^J 
(LXXXII) 
5a-Cholestan-3-one (LXXXIII) yielded different 
compounds under different conditions of bromination. When 
(LXXXIII) was reacted with Br^/HBr in acetic acid for 10 
minutes at room temperature^ the product obtained was 
2a-bromo-5a-cholestan-3-one (DOCXIV)^^*^^. Dibromination 
of the (LXXXIII) with bromine in acetic acid produced 
2a,2p-dibromo-5a-cholestan-3-one (LXXXV) • When bromination 
of the same compound (LXXXIII) was carried under similar 
conditions, i.e. bromine and acetic acid at room temperature, 
for 20 hours, yielded 2a,4a-dibromo~5a-cholestan-3-one 
(LXXXVI)^®. 
52 
98^17 
26 Butenandt et al. reported the bromination of 
5p-cholest-3-one (LXXXVII) by Br2/HBr in acetic acid at room 
temperature. The product obtained was 4p-bromo-5p-
cholestan-3-one (DCXXVIII). 
(LXXXVII) (LXXXVIII) 
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Bromination of (DCXXVII) was studied in d e t a i l by 
29 30 
Shoppee and co-workers • Kinet ica l ly cont ro l led mono-
bromination of (LXXXVIIJ f a i l ed to y ie ld the ax ia l 
4a-broinoketone and gave equator ia l 4^-brojaoketone (DCXXVIIl) 
Dibroinination of (UCXXVII) furnished d i equa to r i a l 2p,4p-
dibromoketone (LXXXIX>. Acid catalysed monobromination of 
(LXXXVIII) a lso afforded the 2p,4p-dibromoketone (IXXXDC). 
^8^17 
' ("xxviiD - (^ ^^ ^^ j 
Bromination of 6-ketone (XC) yielded two products (XCI) 
major and (XCII) minor. The configuration of the bromine in 
(XCI) and CXCIi; was determined with the help of IR and CD 
spectra which indicated half chair conformation for B ring 
31 in these compounds , 
54 
Bromlnation of 3^-acetoxy-5a-cholestan-6-one (XCIIl) 
23 32 33 
was carried out under different reaction conditions * * . 
A variety of compounds were obtained by these reactions 
ixciv-xcvii;. 
^8^17 
(XCIII) 
'^ -^^y 
(XCIV) 
(xcv) (XCVI) 
.-^ 4^ .^ 
0 
(XCVII) 
When (XCIII) was treated with Brg/HBr in ether-acetic 
acid, it invariably afforded 3p-acetoxy-5,7,7-tribroino-5a-
cholestan-6-one (XCVIII)^'*. 
55 
CaH 
(XCIII) 
8"17 
AcO 
.35 
(XCVIII) 
It has been reported''^ ' that the bromination of 
3p-chloro-5a"-cholestan-6-one (XCIX) under different reaction 
conditions, gave 3p~chloro-5a-bromocholestan-6-one (c) and 
when the reaction was carried out at room temperature or 
under reflux, the dibromocompound (Cl) was obtained. 
.36 
CsHi? 
(XCIX) 
Ellis^*' carried out bromination of steroidal ketones 
having an isolated double bond without any effect upon the 
double bond, 3p-hydroxyandrost-5-en-17-one (CII) gave 
56 
3p-hydroxy~16a-bromoandrost-5-en-17-one (CIII) on reaction 
with cupric bromide. 
..Br 
(CII) 
37 
(CIII) 
Kirk et al. reported the bromination of cholest-4-
en-3-one (LXVIII). They carried out the bromination in the 
presence of a proton acceptor (collidine) and 4-bromocholest-
4-en-3-one (CIV) was obtained. Though, it was previously 
A4 
observed that 3-oxo- /y -steroids on bromination with bromine 
in acetic acid or with N-bromosuccinimide in a suitable 
solvent, led, generally to allylic bromination with formation 
of the corresponding 6-bromo and 2,6-dibromo-3-oxo- /\ -
steroids 38 
^8^17 
(LXVIII) (CIV) 
57 
38 A4 Dj eras si and co-workers" dibrominated -^^ ~'-androstene-3, 
17-dione (CV) with bromine and hydrogen bromide in acetic acid 
and got the dibromocompound (CVI). 
(CV) (CVI) 
When (CV) was treated with equimolar quantity of 
N-bromosuccinimide in carbon tetrachloride, simply allylic 
bromination was noticed and 6-bromo- -androstene-3,17-
38 dione (CVII) was obtained . 2a-Bromocholest-4-en-3-one 
(CVIII) on bromination with N-bromosuccinimide afforded 
2a,6p-dibromocholest-4-en-3-one (CIX). 
58 
CoH 8"17 
Be 
Br 
(CVIII) (CDC) 
5a-Cholest-2-en-4-one (CX) in chloroform was treated 
with bromine at 20 , which provided 2p,3a-dibromo-5a-
cholestan-4-one (CXI) i.e. the diaxial addition product 39 
CgHj_7 
(CX) (CXI) 
Broraination of cholest-5-en-4-one (OCII) afforded 
5,6p-dibromo-5a-cholestan-4-one (CXIII) 39 
59 
98^17 
(CXII) 
Reaction of 3p-acetoxy-5, l6-c[ien-20-one (CXIV)^^ 
with cupric bromide in tetrahydrofuran was carried out 
with the thought of producing results and analogous to 
40 those obtained by Sollman and Dodson , i.e. bromine should 
be introduced at C^^ to yield (OCVI) but the product 
obtained was 21-bromo derivative (CXV). 
(CXIV) (CXV) (CXVI) 
D I S C U S S I O N 
Synthesis of Steroidal Ketones. Bromination and Biological 
Activities : 
In the present work we have described the synthesis of 
steroidal ketones such as 5a-cholestane-3,6-dione (LXXIV) 
and cholest-4-en-3,6-dione (LXIV) and bromination of (LXIV) 
and its biological activities. 
Heating under reflux of 22.5.66-tribroiiio~5a~cholestan-3-one 
(GXPC) wUh ^%h^r)9)r : 
The tribromoketone (CXIX) was heated under reflux for 
3 hours on the water bath in ethanol, then worked up in the 
usual manner to provide the brown solid which was chromato-
graphed over silica gel affording a compound, m.p.l70°C. 
Characterisation of the compound having m«p. 170°C as 
5tt-ChQlestane-3.6-dione (LXXIV) : 
^0, The compound with m.p, 170 C was correctly analysed for 
^27^44^2* ^^® '^^ spectrum of the compound showed bands at 
1720 cm"-'" (-C=K)). Its ^H-NMR spectrum exhibited its methyl 
protons at d 0,95 (CJ^Q-CH3), 0.69 (Cj^s-CHg), 0.92, 0.87 and 
13 0,85 (other methyl protons). The C-NMR showed two distinct 
: 6 1 I 
peaks at 211,26 and 209.112 for two carbonyl groups (C.=0 
and C^=0 r e s p e c t i v e l y } . In the mass spectrum of the 
compound, the molecular ion peak was observed at m/z 400(M,) 
The other important fragment ion peaks were at m/z 399, 
386, 373, 372, 288, 273 and 260. The formation of these 
fragment ions are explained in Scheme-1. The X-ray 
s t ruc tu re of the compound i s also given in support of the 
s t r u c t u r e . Thus on the basis of these a n a l y t i c a l and 
spec t r a l data the compound, m.p, 170 C was iden t i f i ed as 
5a-choles tane-3 ,6-dione . 
H39 
HAD 
H2£ H35 H260 H3a 
H17 ^H19^^ H2 
H31 
X-RAY STRUCTURE 
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m/z 398 
m/z 372 
m/z 272 f 
-CHs 
-CH 
+ 
• 
3_ 
m/z 383 
/•. 
-H 
m/z 384 
W z 385 
M 400 
\-C8Hl7 
-H -H' 
m/z 287 .>m/z 286 > ra/z 285 
ko 
-CH^ 
-H' -H' 
m/z 244 <: m/z 259 ^m/z 258 -> m/z 257 
-H 
m/z 243 
SCHEME-1 
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Reaction of SB-hvdroxvcholest-S-ene with Dvrldinium 
dlchromate (PDC) : 
To a solution of 3p-hydroxycholest-5-ene in N,N-
dimethyl formamide, the PDC was added at room temperature 
and stirred with the help of magnetic stirrer for 4 hours. 
After 4 hours the reaction mixture was poured onto the 
water and then worked up with ether and washed with water 
for several times so as to remove the chromate and DhlE, 
The ethereal layer was dried over anhydrous sodium sulphate 
and the resulting solid was crystallised from methanol 
to afford the compound, m.p, 124*^ 0. 
^8^17 
d<J\J 
(LVIII) 
0 
(LXIV) 
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Characterisation of the compound (LXIV) having m.D» 124°C 
as Cholest-4~en--3.6-dione ; 
The compound, m.p. 124 C was correctly analysed for 
^27^42^2* ^^® ^•^* spectrum showed A ^ at 250.5 and IR 
spectrum of the compound showed bands at 1700 and 1620 cm" 
(C=C-C=0). Its H-NMR spectrum exhibited a singlet inte-
grating for one proton at d 6.15 and was assigned to the 
C^-vinylic proton. The methyl protons appeared at 1.15 
(Cj^ Q-CHg) and 0.71 (Cj^g-CHg), 0.91, 0.86 and 0.84 (for 
13 
other methyl protons). The C-NMR revealed two distinct 
peaks for (-C=C-; at 161.052 (C^ )^ and 125.404 (C^). The 
mass spectrum of the compound gave molecular ion and some 
important fragment ions at m/z 398 (Att), 397, 396, 383, 
382, 381, 370, 369, 368, 285, 284, 283, 270, 269 and 257. 
The formation of these fragment ions were explained in the 
Scheme-2. On the basis of these values, the compound, 
m.p. 124°C was identified as cholest-4-en-3,6-dione (LXIV). 
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m/z 269 
m/z 270 
T 
-CH' 
m/z 285 <-
m/z 284 
m/z 283 
""^ 8^ 17 
m/z 368 f 
»m/z 369 
^m/z 381 
ra/z 242 
SCHE^E-2 
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Reaction of cholest'-4-en-3«6~dlone (LXIV) with NBS 
(N~Bromosuccinimlde) in presence of benzoyl peroxide (as 
catalyst,) : 
Cholest-4-en-3,6-dione was dissolved in benzene and 
a little (catalytic) amount of benzoyl peroxide is added 
then in the refluxed mixture, NBS (N-bromosuccinimide) was 
added in small portions over a period of 4 hours. After 
4 hours^the solvent is evaporated under reduced pressure 
and the reaction mixture was taken in ether and washed with 
Water and chxomatographed over silica gel which afforded a 
compound crystallisable in light petrol having m.p. 181°C. 
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Characterisation of the compound having m.p. 181^0 as 
2tt.7a-dibroinocholest~4-en~3.6-cliene (CXVI) : 
The compound having m,p. 181°C was correctly analysed 
for C2'7H^02Br2. The U.V. spectrum of the compound showed 
a X_^„ at 240,8 and in IR spectrum, bands at 1700, 1620 
(C=C-C=0) and 780 cm"^ (C-Br) were observed. Its ^H-NMR 
exhibited a singlet at d 6.32 integrating for one proton 
(C-4, vinylic). A double of doublet was observed at 4.85 
for C2 proton while a doublet at 4,38 for Cy proton. The 
methyl protons appeared at 1,24 (C^Q-CH^), 0,74 (C^s-CH^), 
0,92, 0,87 and 0,85 for other methyl protons. Its ^^C-NMR 
showed peaks at 193.994 for C«0 at C^, 190,377 for C=0 at 
C3, 159.312 for C^, 126,544 for C^, 57.627 and 55.645 for 
Cy and Cg respectively. In its mass spectrum the molecular 
ion peak and some important fragment ions weise*.finaid=.rat:- m/z 
554 (Mt), 556 (M+2), 558 (M+4) (these were in 1:2:1 ratio), 
477/475, 476/474, 396, 395, 394, 381, 368, 283, 268, 255, 
253 and 225. The fragmentation for these ions were 
explained in Scheme-3. On the basis of these analytical 
and spectral data the compound m.p, 181*^ C is characterized 
as 2a,7a-dibromocholest-4-en-3,6-dione (CXVIK Further 
support of this comes from its X-ray analysis. 
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OQH^J + 
hit 554 [M+2 : 556; Mf4:558j 
m/z 381 
tn/z 363 ^ -Co m/z 396 > m/z 395 >m/z 394 
-CH. / ^ -Co . , m/z 283- ->m/z 255 ', 
-CH-: 
240 
m/z 253 
-CO -^H, 
•^ m/z 225 
SCHEME-3 
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H 8 j ^ C l l c i 5 ^ T n 
H20 
_Hdb H39 
f H18 
3H24 H2& (^27^3^;^^ _^ 
' ^ ^ ^^^H2S H3Cu—Yr2B 
X-RAY STRUCTURE 
Biological activities of 2a.7a-dlbroinochQlest-4-en-3.6-dlone 
(CXVI) : 
2a,7a-Dibromocholest-4-en-3,6-dione (CXVI) on blind 
screening showed reduction in Palpebral aperture and 
frequency of spontaneous movements and that its higher 
doses affect the coordination of movement indicates that 
it possesses central depressant action. The decrease in 
body temperature could be due to specific central actions 
or be a part of generalised central depressant. The 
reduction in the tone of the limbs and abdomen could be 
due to the effect of motor neurons or due to generalised 
central depressant. The fact that the compound does not 
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increase the reaction time to both the mechanical and 
thermal nociceptive stimulii indicates that the compound 
probably does not have analgesic action. The lower doses 
i.e. 10 mg/kg and 20 mg/kg produce a narrowing the 
palpebral aperture but do not effect the movements indicate 
that they have only very mild central depressant actions if 
at all. The doses of 30 mg/kg and the higher doses reduce 
the movements, therefore, in the light of present study it 
can be seen that the dose of 30 mg/kg is the minimum dose 
that possesses clear cut central depressant actions. The 
bromoketone produced about 16% mortality at the dose of 
50 mg/kg and 25% at 100 mg/kg. 
The test compound i.e. 2a,7a-dibromocholest-4-en-3,6-
dione (CXVI) is seen to possess unambigous central depressant 
activity and possibly a specific myorelaxant and hypothermic 
activity but no analgesic activity. 
E X P E R I M E N T A L 
3B-Hvdroxv~5.66~dibromo-5tt~cholestane (CXVII) : 
To a solution of cholesterol (14 g) in ether (100 ml) 
was added gradually Br2 solution (5 ml Br^ dissolved in 
100 ml glacial acetic acid containing 2 gm of anhydrous 
sodium acetate) with stirring. The solution truned yellow 
and promptly set to a stiff paste of dibromide. The mixture 
was cooled and stirred with glass rod for 5 minutes to ensure 
complete crystallisation. The product was then filtered 
under suction and washed with cold ether-acetic acid (3:7) 
mixture until the filterate was completely colourless. The 
white dibromide is air dried (15 g), m.p. 113°C (reported , 
m.p. 112-113°C). 
5.aB-Dibromo-Sa-cholestan-S-one (CXVIII) : 
3p-Hydroxy-5,6p-dibromo-5a-cholestane (10 g) was 
suspended in acetone (300 ml) in a three nacked flask fitted 
with a stirrer and a dropping funnel. The suspension was 
stirred for 5 minutes and Jones reagent (15 ml) was then 
added dropwised from a dropping funnel in the course of 15 
minutes. The temperature of the reaction mixture during 
oxidation was maintained between 0-5°C by external cooling. 
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After complete addition, stirring was continued for further 
15 minutes and cold water was then added (200 ml). The 
product thus obtained was filtered and washed with water 
thoroughly under suction and air dried to give the dibromo-
ketone 8.5 (g), m.p. 74°C (reported^^, m.p, 73-75^C). 
2£.5.6B-Tribromo-5tt>cholest-3~one (CXIX) : 
2.2 g of 5,6p-Dibromo-5a-cholestan-3-one was added in 
200 ml of glacial acetic acid and 2 drops of HBr (as catalyst). 
The solution was stirred at room tempersiture with Br^ (2.5 g, 
BT2 in 33 ml acetic acid and few drops of HBr) for 1 hour. 
After addition of BT^ solution, cold water was added and 
white solid was filtered under suction and air dried, 1.9 g, 
m.p, 101-103°C. 
5a~Cholestane-3.6-dione CCXXIV) : 
A solution of 2I,5,6p-5a-cholestan-3-one (1.6 g) in 
ethanol (150 ml) was refluxed for three hours. After three 
hours, the alcohol was evaporated under reduced pressure and 
solid mass was taken in ether. The ethereal solution was 
washed with water and then ether was removed and solid thus 
obtained was chromatographed over silica gel. The elution 
with petroleum ether (60-80°) and ether (2:1) provided a 
: 73 : 
solid which was crystallised from petroleum ether, 300 mg, 
m. i.p. 170°C (reported'*^ , 169°C). 
Analysis found ; C, 81.0; H, 11,0 
Required : C, 80.9; H, 11.1?^  
I.R. : ^ ^ ^ 1720 cm"^ (C=0) 
max • 
^H-NMR (CDCI3) : d 0.95 (s, 3H, C^Q-CHJ), 0.69 (s, C^^-CH^), 
0.92, 0.87 and 0.85 (for other methyl 
protons). 
13 
The C-NMR showed two distinct peaks at 211.26 and 
209.112 for two carbonyl groups (C.=0 and €3=0 respectively). 
Mass : m/z 400(Mt), 399, 386, 373, 288, 273 and 260. 
Preparation of PDC (Pvridiniumdichromate) : 
Chromium trioxide (50 g) was dissolved in 50 ml of 
water and cooled, then 40.6 ml of pyridine is added. The 
resulting solution was cooled to -20°C by external cooling 
and then 200 ml of acetone is added and filtered immediately 
under suction, providing dark red shining crystals, 
m.p. 156 C. 
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Reaction of cholesterol with PDC ; Cholest-4-en-'3.6'-dione 
To a solution of cholesterol (2 g) in 44 ml of 
N,N-dimethylformamide, 8.8 g of HXJ was added and the 
reaction mixture was stirred at room temperature under 
anhydrous conditions for 4 hours* The reaction was monitored 
with the help of TLC plates. After 4 hours, 440 ml of water 
was added and the reaction mixture was worked up with ether 
in the usual manner. The ethereal solution was dried over 
anhydrous sodium sulphate. Evaporation of solvent provided 
yellow solid which was crystallized from methanol, 1.74 g, 
m.p. 124°C (reported"*^ , ra.p. 122-123°C). 
Analysis found : C, 81.4; H, 10,6 
Required : C, 81.2; H, 10.8?^  
U»V. : X „^^ 250.8 nm. max. 
I.R.s'^J^x^'^^ and 1620 cm"^ (C=C-C=0). 
^H-NMR (CDCI3) : d 6.15 (s, IH, C^-vinylic), 1.15 (s, 3H, 
Cj^Q-CHg), and 0.71 (s, 3H, Cj^ g-CHg) 
0.91, 0,86 and 0.84 (other methyl protons). 
•••^ C-NMR : 161.052 and 125.404 for C^ and C^ respectively. 
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Mass : m/z 398 (Mt), 397, 396, 383, 381, 370, 369, 368, 
285, 284, 283, 270, 269 and 257. 
Reaction of cholest"4~en-3.6--dlone (LXIV) with N-bromo-
succlnlmlde (NBS) in presence of benzoyl peroxide (as 
catalyst) : 2tt. 7a«Dibromocholest"4-en-'3.6-dione (OCVI) : 
A solution of 2 g of choiest-4-en-3,6-dione in 60 ml 
dry benzene and benzoyl peroxide (in catalytic amount) was 
added NBS (2 g) gradually in small portions for a period of 
3 hours under reflux conditions. The solution was further 
refluxed for 1 hour. The solvent was evaporated under 
reduced pressure. The resulting solution was taken in ether, 
washed with water and sodium bicarbonate (5^) and again with 
water. The ether layer is collected and dried over anhydrous 
sodium sulphate. Removal of the solvent provided a brown 
solid which was crhomatographed over silica gel. Elution 
with petroleum ether and ether (Ssl) provided the white solid 
which was crystallised from petroleum ether, 1,52 g, 
m.p. 181°C. 
Analysis found : C, 58.02; H, 7.44 
Required : C, 58.27; H, 7.19^. 
U.V. : «,^ 240.8,-y^ m. 
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I.R^;V^3xi'7^» 1620 (C=C-C=0) and 780 cm"^ (C-Br). 
^H-fWR, : d 6.32 (s, IH, C-4 vinylic), 4.85 (dd, IH, C-2), 
KKAJ^x^j ^^^g ^^ ^ ^^ ^^^^^ ^^24 (C^Q-CHg), 0,74 (s, 3H, 
^13"^^3^ and 0.92, 0.87 and 0.85 (other methyl 
protons). 
^^C-NMR : 193.994 (C^=0), 190.377 (Cg^O), 159.312 and 
126.544 (0^=04), 57.627 and 55.645 for C^ and 
C2 respectively. 
Mass : ra/z 544 (Mt), 556 (M+2), 558 (M+4) (in 1:2:1 ratio), 
477/475, 476/474, 396, 395, 394, 381, 368, 283, 268, 
255, 253, 240 and 225. 
PHARMACOLOGICAL TESTING : 
Gross Behaviour Test of 2a. 7a-dibromocholest-4~en~3.6-dione 
(CXVI) : 
44 The test was carried out by the method of Smith with 
45 
modification in the light of Irwin's method . The method 
is a simple but comprehensive detecting a large number of 
neuropharmacological actions. As it is usual to begin with 
30 mg/kg for blind screening because the test compound has 
77 
no pharmacological history . Howevel-~t"Keiower as well 
as higher doses were also used. The compound was suspended 
in propylene glycol and injected in tetraperitoneally. The 
effect of bromoketone was studied at the dose of 10 mg/kg, 
20 mg/kg, 30 mg/kg, 40 mg/kg, 50 mg/kg and 100 mg/kg. Each 
dose was tested in 6 mice of either sex weighing 20-25 gms< 
The animals were observed for various parameter listed in 
Table-I. The mechanical and thermal nociceptive stimulus 
was given by applying a sheathed bull dog clamp at the tail 
and placing the animal on Eddy*s Hot Plate at 55.5°C 
respectively. The animals were continuously observed for 
6 hours and then at 24 hours. They were observed subsequently 
for mortality at 24 hours for 6 days. 
The bromoketone (OCVI) was found to produce narrowing 
of the palpebral aperture at all the doses. The spontaneous 
movements were found to be increasing by decreased at the 
dose of 30 mg/kg, 40 mg/kg, 50 mg/kg and 100 mg/kg. The 
compound did not affect the movements at 10 mg/kg and 
20 mg/kg. The higher doses viz. 50 mg/kg and 100 mg/kg 
produced a staggering gait. All the doses increased the 
rate of respiration and decreased the depth of respiration. 
The body temperature was found to be reduced by all the doses 
of the compound except the dose of 10 mg/kg. Similarly the 
limb and abdominal tone was reduced by all the doses except 
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the dose of 10 mg/kg. The compound did not increase the 
reaction time to the mechanical as well as nociceptive 
stimulus. Straub*s response was not observed* The reflexes 
were also not effected. Salivation, Lacrimation and exce-
ssive urination were also not seen. The result is presented 
in Table-I. 
TABLE-X. Effective of various doses of the 2a.7a-Dibromo-
cholest-4-en--3.6~dione on behaviour of mice 
S, Parameters 10 mg/ 20 mg/ 30 mg/ 40 mg/ 50 mg/ 100 mg/ 
No. kg kg kg kg kg kg 
1. 
2. 
3. 
4. 
5. 
6. 
7, 
8. 
9. 
10. 
11. 
12. 
Time of first 
unusual S/S 
Movements 
Co-ordination 
Palpebral 
aperture 
Alertness 
Grooming 
Restlessness 
Stereotypy 
Tremour 
Convulsions 
Rate of 
respiration 
Depth of 
respiration 
50 
mints 
N 
N 
1 
N 
N 
A 
A 
A 
A 
N 
N 
50 
mints 
N 
N 
I 
N 
N 
A 
A 
A 
A 
T 
I 
50 
mints 
1 
^ 
i 
N 
N 
A 
A 
A 
A 
t 
i 
50 
mints 
1 
vl' 
4/ 
^^  
N 
A 
A 
A 
A 
t 
4. 
50 
mints 
U 
^ 
^^  
vl 
N 
A 
A 
A 
A 
t 
i 
50 
mints 
il 
I 
^ 
4, 
N 
A 
A 
A 
A 
t 
^ 
Contd••• 
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TABLE-I Contd... 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
Body 
Temperature 
Piloerection 
Limb tone 
Abdominaltone 
Pinna reflex 
Corneal reflex 
Lacrimation 
Salivation 
Urination 
Excessive 
defecation 
Startle 
response 
Touch 
response 
Straub's 
response 
Mortality 
N 
A 
N 
N 
N 
N 
A 
A 
N 
No 
+ve 
+ve 
-ve 
Nil 
^ 
A 
N 
N 
N 
N 
A 
A 
N 
No 
+ve 
+ve 
-ve 
Nil 
^ 
A 
4 
4 
N 
N 
A 
A 
N 
No 
+V€ 
+ve 
-ve 
Nil 
^ 
A 
^ 
4 
N 
N 
A 
A 
N 
No 
+ve 
+ve 
-ve 
Nil 
4 
+ve 
^ 
4 
N 
N 
A 
A 
N 
No 
+ve 
+ve 
-ve 
1/6 
4 
+ve 
4^  
4^  
N 
N 
A 
A 
N 
No 
+ve 
+ve 
+ve 
1/4 
N = normal, A = Absent, +ve = Positive, -ve = Negative 
t^Increased, ^ » Decreased, 
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